Medical Device

The largest neutral healthcare conference in Europe for life sciences professionals to address the hottest challenges. As the knowledge and innovation hub uniting science, healthcare, patients and regulatory professionals, DIA Europe commits to transforming insights into action by bridging the gap between critical policy discussions and real-world expertise. 

The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region. It has been connecting life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation since 2018.

A two-day London event with the leading expertise on innovative formulation strategies and technologies, as well as the research improving the delivery of complex therapeutics. 2 events in one: 9th Annual Formulation & Drug Delivery Congress and 8th Annual Inhalation & Respiratory Drug Delivery Congress

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forwardthinking approaches for implementing digital technology to improve clinical trials.

DIA has been the world’s leading member-based, non-profit organization driving innovation in patient safety and outcomes. We attract thousands of leading international life sciences organizations from Pharma, Biotech, Medical Device, and Diagnostic Equipment together with global regulatory agencies and leading academic researchers in a neutral, collaborative environment.

The Canada Annual Meeting will deliver a comprehensive overview of the current biopharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships, to key regulatory, clinical, and safety considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Baird is delighted to host its annual Global Healthcare Conference. This conference brings institutional and private equity investors together with senior management from over 90 public and privately-held companies. The conference will feature companies across the following sectors: Biotechnology, Healthcare Supply Chain & Pharma Services, Healthcare Information Technology, Life Sciences & Diagnostics, Medical Technology and Facilities & Services. 

AusMedtech is Australia’s premier medical technology conference for medtech executives, providing business partnering opportunities for decision makers and investors.

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.

Over 370 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will attend Anglonordic Life Science Conference. With over 90 investment firms participating, on-point panel discussions and 36 funding pitches presented by cutting-edge biomedical and healthcare startups, this was the culmination of the conference’s 2 decades as the unique R&D-to-investor conference in the UK.